Pharma4ever Engineering ApS: Financial statements 2025
CVR: 41699477
Source: annual report 2025, Danish Business Authority
01/01/2025 – 31/12/2025
Pharma4ever Engineering ApS (CVR 41699477) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK 12,586,113 and a net result of DKK 2,325,191 compared with DKK 1,037,826 the year before. That is a decrease of 11.5% compared with the year before. Equity in the 2025 report amounted to DKK 2,365,191. The solvency ratio was 42.4%.
- Gross Profit
- DKK 12,586,113
- Profit/Loss
- DKK 2,325,191
- Equity
- DKK 2,365,191
- Total Assets
- DKK 5,581,991
- Employees
- 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2025 | - | 12.6 mio. | 2.3 mio. | 2.4 mio. | 0 |
| 2024 | - | 14.2 mio. | 1 mio. | 1.1 mio. | 13 |
| 2023 | - | 14.8 mio. | 3 mio. | 3.2 mio. | 11 |
| 2022 | - | 3.8 mio. | 671 t. | 788 t. | 3 |
How creditworthy is Pharma4ever Engineering ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2025
Pharma4ever Engineering ApS has published its annual report for 2024. Gross profit came to DKK 14,219,641, and the net result was DKK 1,037,826.
About Pharma4ever Engineering ApS
Pharma4ever Engineering ApS is a Danish company of the type Anpartsselskab based in Tikøb, founded in 2020. The company is registered under the industry Anden teknisk rådgivning. The management consists of Jonas Mortensen Højslet. The company is owned by BHP Holding ApS, Andresen Holding af 29. maj 2015 ApS and Finished Goods Engineering ApS. In 2025, the company reported a gross profit of DKK 12,586,113 and a net result of DKK 2,325,191 compared with DKK 1,037,826 the year before. Equity in the 2025 report amounted to DKK 2,365,191.